New partnership set to help ‘transform’ access to medicines for patients in Greater Manchester
A unique partnership announced today by the pharmaceutical industry and Greater Manchester Health and Social Care Partnership will help the city region deliver its vision to be the safest and most effective place to receive medicines in the world – and cement its position on the global research and development map.
The collaboration, in the form of a Memorandum of Understanding, will create a Greater Manchester and Pharmaceutical Industry Partnership Group. The group will improve the use and safety of medicines and use the unique data and information capabilities of the NHS to discover, develop, and deliver new medicines and treatments for patients.
The agreement will allow Greater Manchester to explore new ways of paying for medicines based on patient outcomes - enabling the £1 billion spent on medicines in the region to be as effective as possible.Download the Memorandum of Understanding (MoU) between Greater Manchester Health and Social Care Partnership and ABPI